Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 1, 1998, Pages 548-554

  Pardridge, William M ^a   Buciak, Jody ^a   Yang, Jing ^a   Wu, DaFang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; ONCOPROTEIN;

ANTIBODY AFFINITY; ANTIBODY CATIONIZATION; ANTIGEN BINDING; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL MEMBRANE; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENDOCYTOSIS; EXTRAVASCULAR SPACE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; ENDOCYTOSIS; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0031869867     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Baulida J, Kraus MH, Alimandi M, Di Fiore PP and Carpenter G (1996) All ErbB receptors other than the epidermal growth factor receptor are endocytosis impared. J Biol Chem 271:5251-5257.
2. Bickel U, Lee VMY, Trojanowski JQ and Pardridge WM (1994) Development and in vitro characterization of a cationized monoclonal antibody against BA4 protein: A potential probe for Alzheimer's disease. Bioconjug Chem 5:119-125.
3. HER2 antibody for human cancer therapy. Proc Natl Acad Sci USA 89:4285-4289.
4. DeSantes KD, Slamon D, Anderson SK, Shepard M, Fendly B, Maneval D and Press O (1992) Radiolabeled antibody targeting of HER-2/neu oncoprotein. Cancer Res 52:1916-1923.
5. Giovanella BC, Vardeman DM, Williams LJ, Taylor DJ, DeIpolyi PD, Greeff PJ, Stehlin JS, Ullrich A, Cailleau R, Slamon DJ and Howard EG (1991) Heterotransplantation of human breast carcinomas in nude mice. Correlation between successful heterotransplants, poor prognosis and amplification of the HER-2/neu oncogene. Int J Cancer 47:66-71.
6. neu) in prostate tumors: an immunohistochemical study. The Prostate 23:329-336.
7. Hsu S-M, Raine L and Fanger H (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
8. Jain RK (1996) Delivery of molecular medicine to solid tumors. Science 271:1079-1080.
9. HER2 antibody. Am J Respir Cell Mol Biol 9:448-454.
10. Muckerheide A, Apple RJ, Pesce AJ and Michael JG (1987): Cationization of protein antigens. J Immunol 138:833-837.
11. Pardridge WM, Kang Y-S, Yang J and Buciak JL (1995) Enhanced cellular uptake and in vivo biodistribution of a monoclonal antibody following cationization. J Pharm Sci 84:943-948.
12. Pardridge WM, Kang Y-S, Diagne A and Zack JA (1996) Cationized hyperimmune immunoglobulins: pharmacokinetics, toxicity evaluation and treatment of human immunodeficiency virus-infected human-peripheral blood lymphocytes-severe combined immune deficiency mice. J Pharmacol Exp Ther 276:246-252.
13. Pardridge WM, Kang Y-S and Buciak JL (1994a) Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm Res. 11:738-746.
14. Pardridge WM, Bickel U, Buciak J, Yang J and Diagne A (1994b) Enhanced endocytosis and anti-HIV-1 activity of anti-rev antibodies following cationization. J Infect Dis 169:55-61.
15. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, Paterson MC and Slamon DJ (1993) Her-2/neu expression in node-negative breast cancer; direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res 53:4960-4970.
16. Saga T, Neumann RD, Heya T, Sato J, Kinuya S, Le N, Paik CH and Weinstein JN (1995) Targeting cancer micrometastases with monoclonal antibodies: A binding-site barrier. Proc Natl Acad Sci USA 92:8999-9003.
17. Scott GK, Robles R, Park JW, Montgomery PA, Daniel J, Holmes WE, Lee, L, Keller GA, Li WL, Fendly BM, Wood WI, Shepard HM and Benz CC (1993) A truncated intracellular HER2neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol Cell Biol 13:2247-2257.
18. Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Pallidino MA, Ullrich A and Slamon D (1991) Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic. J Clin Immunol 11:117-127.
19. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL (1987): Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene. Science 235:177-182.
20. HER2 and growth inhibition of cells with HER2/neu gene amplication. Int J Cancer 47:933-937.
21. Triguero D, Buciak JB, Yang J and Pardridge WM (1989) Blood-brain barrier transport of cationized immunoglobulin G; enhanced delivery compared to native protein Proc Natl Acad Sci USA 86:4761-4765.
22. Triguero D, Buciak JB and Pardridge WM (1990) Capillary depletion method for quantifying blood-brain barrier transcytosis of circulating peptides and plasma proteins. J Neurochem 54:1882-1888.